argenx SE | Results Presentation Deck | 20 slides · page 9 of 20
The slide outlines the dosing schedule (weeks 1-4, 5-16, and beyond) and the primary objective for the trials.
Conference presentation · other · present_framework · balanced density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 diagram 1/1 metric 2/2 title 1/1
Components 5
primary process big-number big-number headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1